Funatomi H - Search Results

1

Increased expression of keratinocyte growth factor in human pancreatic cancer.

Siddiqi I, Funatomi H, Kobrin MS, Friess H, Büchler MW, Korc M. Siddiqi I, et al. Among authors: funatomi h. Biochem Biophys Res Commun. 1995 Oct 4;215(1):309-15. doi: 10.1006/bbrc.1995.2467. Biochem Biophys Res Commun. 1995. PMID: 7575607

2

Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.

Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Bergmann U, et al. Among authors: funatomi h. Cancer Res. 1995 May 15;55(10):2007-11. Cancer Res. 1995. PMID: 7743492

3

Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer.

Kobrin MS, Funatomi H, Friess H, Buchler MW, Stathis P, Korc M. Kobrin MS, et al. Among authors: funatomi h. Biochem Biophys Res Commun. 1994 Aug 15;202(3):1705-9. doi: 10.1006/bbrc.1994.2131. Biochem Biophys Res Commun. 1994. PMID: 8060360

4

Increased expression of insulin receptor substrate-1 in human pancreatic cancer.

Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M. Bergmann U, et al. Among authors: funatomi h. Biochem Biophys Res Commun. 1996 Mar 27;220(3):886-90. doi: 10.1006/bbrc.1996.0500. Biochem Biophys Res Commun. 1996. PMID: 8607861

5

Heparin-binding EGF-like growth factor expression and biological action in human pancreatic cancer cells.

Yokoyama M, Funatomi H, Hope C, Damm D, Friess H, Buchler M, Abraham J, Korc M. Yokoyama M, et al. Among authors: funatomi h. Int J Oncol. 1996 Feb;8(2):289-95. doi: 10.3892/ijo.8.2.289. Int J Oncol. 1996. PMID: 21544358

6

Betacellulin, a member of the epidermal growth-factor family, is overexpressed in human pancreatic-cancer.

Yokoyama M, Funatomi H, Kobrin M, Ebert M, Friess H, Buchler M, Korc M. Yokoyama M, et al. Among authors: funatomi h. Int J Oncol. 1995 Oct;7(4):825-9. doi: 10.3892/ijo.7.4.825. Int J Oncol. 1995. PMID: 21552910

7

Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.

Funatomi H, Itakura J, Ishiwata T, Pastan I, Thompson SA, Johnson GR, Korc M. Funatomi H, et al. Int J Cancer. 1997 Jul 29;72(3):512-7. doi: 10.1002/(sici)1097-0215(19970729)72:3<512::aid-ijc21>3.0.co;2-c. Int J Cancer. 1997. PMID: 9247297

8

Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1.

Bergmann U, Funatomi H, Kornmann M, Ishiwata T, Beger H, Korc M. Bergmann U, et al. Among authors: funatomi h. Int J Oncol. 1996 Sep;9(3):487-92. doi: 10.3892/ijo.9.3.487. Int J Oncol. 1996. PMID: 21541539

9

Amphiregulin is a potent mitogen in human pancreatic-cancer cells - correlation with patient survival.

Yokoyama M, Ebert M, Funatomi H, Friess H, Buchler M, Johnson G, Korc M. Yokoyama M, et al. Among authors: funatomi h. Int J Oncol. 1995 Mar;6(3):625-31. doi: 10.3892/ijo.6.3.625. Int J Oncol. 1995. PMID: 21556580

10

Hepatocyte growth factor stimulates cell growth and enhances the expression of transforming growth factor alpha mRNA in AsPC-1 human pancreatic cancer cells.

Ohba N, Funatomi H, Seki T, Makino R, Mitamura K. Ohba N, et al. Among authors: funatomi h. J Gastroenterol. 1999 Aug;34(4):498-504. doi: 10.1007/s005350050303. J Gastroenterol. 1999. PMID: 10452684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters